Chiesi Group’s new Biotech Center of Excellence brings new jobs

Chiesi Group’s new Biotech Center of Excellence brings new jobs

by admin November 28, 2022 November 28, 2022 No comments

The Chiesi pharmaceutical group celebrated in Parma the “Start of Work” on the Biotech Center of Excellence, the new Italian and international center of excellence for the development and production of biologic drugs.

The Center, which will become fully operational in 2024, projecting itself into the future of medicine, will specialise in the development and production of the active ingredients of monoclonal antibodies (produced through recombinant DNA techniques starting from a single type of immune cell), enzymes and other proteins. From cells to the finished drug and packaging for the global market, attracting talent and technical skills to Italy that are crucial to further developing the specialised expertise already present in the country.

The creation of the Biotech Center of Excellence is Chiesi’s response to the challenges highlighted by the pandemic, which revealed a need to improve the resilience of the healthcare system, including improvements in sustainability. Today, only 22% of all new treatments developed worldwide originate in European countries, and this is partly caused by slower growth in R&D investment across the region.

The Group continues to invest in the region, carrying out projects that produce value and new highly qualified jobs. The new therapeutic opportunities offered by the Biotech Center of Excellence will allow the company to become a major player in the biopharmaceutical sector, an industry that has been constantly growing for around 10 years.

Leave comments

Your email address will not be published.*

<br><br>You may use these <abbr title="HyperText Markup Language">HTML</abbr> tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Supportscreen tag